V
主页
Fate Therapeutics Introduction
发布人
打开封面
下载高清视频
观看高清视频
视频下载器
Engineering iPSC-derived Natural Killer Cells
Off-the-shelf NK cell therapy [WEBINAR]
Dan Kaufman-Shoreline Biosciences
Evaluating expression patterns of multiple inhibitory and stimulatory receptors
Dan Kaufman - iPSC Derived NKs_ Targeting Cancer with an Engineered, iPSC-Derive
Serum-free Expansion of NK Cells with K562- Based Feeder Systems for Clinical Ap
Blocking ADAM17 as a therapeutic approach to increase human NK cell proliferatio
Michel Sadelain - iPSC Derived CAR-Ts Targeting Cancer with an Engineered- iPSC-
温度分布验证相关考虑
High-Quality Plasmid DNA Manufacturing Strategies for Gene and Cell Therapeutics
湿热灭菌的科学原理
计算机化系统GMP要求
实验室记录与数据管理
VHP气相灭菌技术
生物制药质量管理
Natural Killer (NK) Cells Defenders Against Cancer
Achieving clinical quality for human iPSC generation and expansion
Megakaryopoiesis
An Introduction to Good Manufacturing Practice - Pharmaceutical and Biotechnolog
消毒技术
FT596_ iPSC-derived CAR-NK cells with engineered persistence for B-cell malignan
公用工程系统GMP合规性
细胞库GMP管理要求
Manufacturing of gene-engineered hematopoietic stem cells
Quality Control development for iPSC banks
GMP物料管理系统
QA人员现场管理
Cell therapy logistics_ Exploring the last 100m
洁净厂房施工与验收标准
建立符合FDA标准的研发QA体系
包材相容性密封性
CAR-NK疗法的研发-从临床前研究思路到NK包最新临床研究进展
Bioreactor discussion
Megakaryopoiesis and Thrombopoiesis
临床试验用药品GMP附录最新解析
生物制品GMP检查要点及常见缺陷
生物制药的GMP检查要求
GMP附录-细胞治疗产品解读
CAR-T Generation for Identity, Purity and Potency Assay Testing
药品技术转移的法规要求和关键点分析